Trial intelligence / Profile preview

FX006 PK/PD Study in Knee Osteoarthritis

NCT01487200Phase 2Completed

Sponsor
Pacira BioSciences
Start
Jul 2012
Primary completion
Nov 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of triamcinolone acetonide in knee osteoarthritis (OA), sponsored by Pacira BioSciences. Started Jul 2012; status: completed.

02

Drugs

triamcinolone acetonide
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT01487200.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01487200.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call